NCT06231680 2024-03-29
Thalidomide Prevention or Treatment of Camrelizumab-induced Reactive Cutaneous Capillary Endothelial Proliferation (RCCEP)
Henan Cancer Hospital
Phase 2 Unknown
Henan Cancer Hospital
Fujian Cancer Hospital
ChineseAMS
The First People's Hospital of Hefei
Changzhou No.2 People's Hospital
Zhengzhou University
National Cancer Institute (NCI)
The First Affiliated Hospital of Xiamen University
Fudan University
National Cheng-Kung University Hospital
National Taiwan University Hospital